Report cover image

Peripheral Neuropathy Global Market Report 2025

Published Sep 10, 2025
Length 250 Pages
SKU # BRC20385393

Description

Peripheral Neuropathy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on peripheral neuropathy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for peripheral neuropathy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The peripheral neuropathy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Type: Chemotherapy-Induced; Diabetic; Human Immunodeficiency Virus (HIV) Or Acquired Immunodeficiency Syndrome (AIDS Associated; Idiopathic

2) By Diagnosis: Blood Test; Biopsy; Imaging; Other Diagnosis

3) By Treatment: Medications; Antidepressants; Anti-Seizure Medication; Pain Reliever; Topical Treatment; Therapies; Nerve Stimulation; Plasma Exchange; Physical Therapy; Other Treatments

4) By End-User: Hospitals; Clinics; Ambulatory Centers

Subsegments:

1) By Chemotherapy-Induced: Taxane-Induced Peripheral Neuropathy; Platinum-Based Drug-Induced Neuropathy; Other Chemotherapy-Induced Neuropathies

2) By Diabetic: Type 1 Diabetes-Induced Peripheral Neuropathy; Type 2 Diabetes-Induced Peripheral Neuropathy

3) By Human Immunodeficiency Virus (HIV) Or Acquired Immunodeficiency Syndrome (AIDS) Associated: HIV-Associated Peripheral Neuropathy; AIDS-Related Peripheral Neuropathy

4) By Idiopathic: Acute Idiopathic Neuropathy; Chronic Idiopathic Neuropathy

Companies Mentioned: Pfizer Inc.; Merck and Co. Inc.; Novartis AG; Bristol Myers Squibb Co; AstraZeneca Plc; Abbott Laboratories; Eli Lilly and Co.; Asahi Kasei Corporation; Daiichi Sankyo Co. Ltd.; Sun Pharmaceutical Industries Ltd; Aurobindo Pharma; Cadila Pharmaceuticals Ltd.; Dr. Reddy's Laboratories; Cipla Ltd.; Apotex Inc; Hikma Pharmaceuticals PLC; Lupin Limited; Grunenthal GmbH; ACI Limited; Lexicon Pharmaceuticals; Solasia Pharma KK; Helixmith Co. Ltd.; PledPharma AB

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery Format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Table of Contents

250 Pages
1. Executive Summary
2. PEGylated Proteins Market Characteristics
3. PEGylated Proteins Market Trends And Strategies
4. PEGylated Proteins Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global PEGylated Proteins Growth Analysis And Strategic Analysis Framework
5.1. Global PEGylated Proteins PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global PEGylated Proteins Market Growth Rate Analysis
5.4. Global PEGylated Proteins Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global PEGylated Proteins Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global PEGylated Proteins Total Addressable Market (TAM)
6. PEGylated Proteins Market Segmentation
6.1. Global PEGylated Proteins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Consumable And Services
PEGylation Kits And Reagents
Monofunctional Linear PEGs
Bifunctional PEGs
Other Products
6.2. Global PEGylated Proteins Market, Segmentation By Protein Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Colony Stimulating Factors
Interferons
Erythropoietin
Recombinant Factor VII
Other Protein Types
6.3. Global PEGylated Proteins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cancer Treatment
Hepatitis
Chronic Kidney Diseases
Hemophilia
Multiple Sclerosis
Gastrointestinal Disorders
Other Applications
6.4. Global PEGylated Proteins Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pharmaceuticals
Biotechnology Companies
Contract Research Organizations
Academic Research Institutes
6.5. Global PEGylated Proteins Market, Sub-Segmentation Of Consumable And Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Consumables
Services (Contract Services, PEGylation Services)
6.6. Global PEGylated Proteins Market, Sub-Segmentation Of PEGylation Kits And Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
PEGylation Kits
Reagents
6.7. Global PEGylated Proteins Market, Sub-Segmentation Of Monofunctional Linear PEGs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Monofunctional PEGs For Protein Modification
6.8. Global PEGylated Proteins Market, Sub-Segmentation Of Bifunctional PEGs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Bifunctional PEGs For Protein Modification
6.9. Global PEGylated Proteins Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Conjugates
PEGylated Drugs And Therapeutics
7. PEGylated Proteins Market Regional And Country Analysis
7.1. Global PEGylated Proteins Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global PEGylated Proteins Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific PEGylated Proteins Market
8.1. Asia-Pacific PEGylated Proteins Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific PEGylated Proteins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific PEGylated Proteins Market, Segmentation By Protein Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific PEGylated Proteins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China PEGylated Proteins Market
9.1. China PEGylated Proteins Market Overview
9.2. China PEGylated Proteins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China PEGylated Proteins Market, Segmentation By Protein Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China PEGylated Proteins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India PEGylated Proteins Market
10.1. India PEGylated Proteins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India PEGylated Proteins Market, Segmentation By Protein Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India PEGylated Proteins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan PEGylated Proteins Market
11.1. Japan PEGylated Proteins Market Overview
11.2. Japan PEGylated Proteins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan PEGylated Proteins Market, Segmentation By Protein Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan PEGylated Proteins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia PEGylated Proteins Market
12.1. Australia PEGylated Proteins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia PEGylated Proteins Market, Segmentation By Protein Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia PEGylated Proteins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia PEGylated Proteins Market
13.1. Indonesia PEGylated Proteins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia PEGylated Proteins Market, Segmentation By Protein Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia PEGylated Proteins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea PEGylated Proteins Market
14.1. South Korea PEGylated Proteins Market Overview
14.2. South Korea PEGylated Proteins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea PEGylated Proteins Market, Segmentation By Protein Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea PEGylated Proteins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe PEGylated Proteins Market
15.1. Western Europe PEGylated Proteins Market Overview
15.2. Western Europe PEGylated Proteins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe PEGylated Proteins Market, Segmentation By Protein Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe PEGylated Proteins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK PEGylated Proteins Market
16.1. UK PEGylated Proteins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK PEGylated Proteins Market, Segmentation By Protein Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK PEGylated Proteins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany PEGylated Proteins Market
17.1. Germany PEGylated Proteins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany PEGylated Proteins Market, Segmentation By Protein Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany PEGylated Proteins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France PEGylated Proteins Market
18.1. France PEGylated Proteins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France PEGylated Proteins Market, Segmentation By Protein Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France PEGylated Proteins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy PEGylated Proteins Market
19.1. Italy PEGylated Proteins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy PEGylated Proteins Market, Segmentation By Protein Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy PEGylated Proteins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain PEGylated Proteins Market
20.1. Spain PEGylated Proteins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain PEGylated Proteins Market, Segmentation By Protein Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain PEGylated Proteins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe PEGylated Proteins Market
21.1. Eastern Europe PEGylated Proteins Market Overview
21.2. Eastern Europe PEGylated Proteins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe PEGylated Proteins Market, Segmentation By Protein Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe PEGylated Proteins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia PEGylated Proteins Market
22.1. Russia PEGylated Proteins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia PEGylated Proteins Market, Segmentation By Protein Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia PEGylated Proteins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America PEGylated Proteins Market
23.1. North America PEGylated Proteins Market Overview
23.2. North America PEGylated Proteins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America PEGylated Proteins Market, Segmentation By Protein Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America PEGylated Proteins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA PEGylated Proteins Market
24.1. USA PEGylated Proteins Market Overview
24.2. USA PEGylated Proteins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA PEGylated Proteins Market, Segmentation By Protein Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA PEGylated Proteins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada PEGylated Proteins Market
25.1. Canada PEGylated Proteins Market Overview
25.2. Canada PEGylated Proteins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada PEGylated Proteins Market, Segmentation By Protein Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada PEGylated Proteins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America PEGylated Proteins Market
26.1. South America PEGylated Proteins Market Overview
26.2. South America PEGylated Proteins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America PEGylated Proteins Market, Segmentation By Protein Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America PEGylated Proteins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil PEGylated Proteins Market
27.1. Brazil PEGylated Proteins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil PEGylated Proteins Market, Segmentation By Protein Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil PEGylated Proteins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East PEGylated Proteins Market
28.1. Middle East PEGylated Proteins Market Overview
28.2. Middle East PEGylated Proteins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East PEGylated Proteins Market, Segmentation By Protein Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East PEGylated Proteins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa PEGylated Proteins Market
29.1. Africa PEGylated Proteins Market Overview
29.2. Africa PEGylated Proteins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa PEGylated Proteins Market, Segmentation By Protein Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa PEGylated Proteins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. PEGylated Proteins Market Competitive Landscape And Company Profiles
30.1. PEGylated Proteins Market Competitive Landscape
30.2. PEGylated Proteins Market Company Profiles
30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Bristol Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
30.2.4. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
31. PEGylated Proteins Market Other Major And Innovative Companies
31.1. Gilead Sciences Inc.
31.2. Novo Nordisk A/S
31.3. Evonik Industries AG
31.4. Viatris Inc.
31.5. Regeneron Pharmaceuticals Inc.
31.6. Biogen Inc.
31.7. Vertex Pharmaceuticals Incorporated
31.8. Lonza Group Ltd.
31.9. Jazz Pharmaceuticals plc
31.10. Ipsen Pharma
31.11. Kyowa Kirin Co. Ltd.
31.12. WuXi Biologics
31.13. BioMarin Pharmaceutical Inc.
31.14. Ligand Pharmaceuticals Incorporated
31.15. Zydus Cadila
32. Global PEGylated Proteins Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The PEGylated Proteins Market
34. Recent Developments In The PEGylated Proteins Market
35. PEGylated Proteins Market High Potential Countries, Segments and Strategies
35.1 PEGylated Proteins Market In 2029 - Countries Offering Most New Opportunities
35.2 PEGylated Proteins Market In 2029 - Segments Offering Most New Opportunities
35.3 PEGylated Proteins Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.